FDA Adverse Event Death Summary report: N

OMNIPOD INSULIN PUMP

MDR report key: 5698742 · Received June 3, 2016

Report

Report Number
3004464228-2016-01544
Event Type
Death
Date Received
June 3, 2016
Date of Event
April 11, 2016
Report Date
June 1, 2016
Manufacturer
INSULET CORPORATION
Product Code
LZG
PMA / PMN Number
K122953
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE RETURNED PRODUCT WAS EVALUATED AND PERFORMED AS DESIGNED. NO DEFECT OR DEFICIENCY THAT WOULD RESULT IN THE REPORTED DIABETIC KETOACIDOSIS (DKA). LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA.THE OMNIPOD¿S USER GUIDE WARNS TO "TEST RESULTS GREATER THAN 250 MG/DL MEAN HIGH BLOOD GLUCOSE (HYPERGLYCEMIA). IF YOU GET RESULTS ABOVE 250 MG/DL, BUT DO NOT HAVE SYMPTOMS OF HYPERGLYCEMIA, REPEAT THE TEST. IF YOU HAVE SYMPTOMS OR CONTINUE TO GET RESULTS ABOVE 250 MG/DL, FOLLOW THE TREATMENT ADVICE OF YOUR HEALTHCARE PROVIDER," AND "IF LEFT UNTREATED, DKA CAN CAUSE BREATHING DIFFICULTIES, SHOCK, COMA, AND EVENTUALLY DEATH." IT ADVISES ¿THE EASIEST AND MOST RELIABLE WAY TO AVOID DKA IS BY CHECKING YOUR BLOOD GLUCOSE AT LEAST 4¿6 TIMES A DAY. ROUTINE CHECKS ALLOW YOU TO IDENTIFY AND TREAT HIGH BLOOD GLUCOSE BEFORE DKA DEVELOPS."

Description of Event or Problem · 1

A MEDICAL EXAMINER CALLED TO REPORT THE DEATH OF A PATIENT WEARING THE OMNIPOD. THE CAUSE OF DEATH WAS IDENTIFIED AS DIABETIC KETOACIDOSIS (DKA) WITH A SECONDARY CAUSE BEING HYPERTENSIVE HEART DISEASE. THE MEDICAL EXAMINER REQUESTED THE POD BE EVALUATED TO RULE OUT A MALFUNCTION OF THE DEVICE. IT WAS NOTED THAT THE PATIENT WAS LAST KNOWN TO BE ALIVE ON (B)(6) 2016 AND FOUND DECEASED ON (B)(6) 2016 BY THE LOCAL POLICE DEPARTMENT. THE PERSONAL DIABETES MANAGER (PDM) NEEDED FOR USE WITH THE POD WAS NOT FOUND WITH THE PATIENT OR AT THE PATIENT'S HOME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
352711 OMNIPOD INSULIN PUMP PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 14000 L42225

Patients

Seq Age Sex Outcome Treatment
1 56 YR Death